Treatment of Urinary Tract Infections in the 3rd Trimester of Pregnancy
For urinary tract infections during the 3rd trimester of pregnancy, second-generation cephalosporins are the recommended first-line empiric treatment to ensure optimal clinical and microbiological cure rates while minimizing risks to mother and fetus. 1
Diagnostic Considerations
- Obtain urine culture before initiating antibiotics to confirm diagnosis and guide targeted therapy 1
- Significant bacteriuria is defined as ≥50,000 CFUs/mL of a single urinary pathogen 2
- Document symptoms and assess severity to determine appropriate treatment setting (outpatient vs. inpatient) 1
Treatment Algorithm
First-Line Treatment Options:
- Second-generation cephalosporins (e.g., cefuroxime) are recommended as first-line empiric therapy 1
- Dosing for oral cefuroxime axetil: 20-30 mg/kg per day in 2 doses 2
Second-Line Treatment Options:
- Aminoglycosides (e.g., gentamicin) may be used as second-line therapy in 2nd and 3rd trimester when benefits outweigh risks 1
- Dosing for parenteral gentamicin: 7.5 mg/kg per day, divided every 8 hours 2
Third-Line Treatment Options:
- Third-generation cephalosporins (e.g., ceftriaxone, cefotaxime) should be used as third-line options due to risk of inducing antimicrobial resistance 1
- Dosing for parenteral ceftriaxone: 75 mg/kg, every 24 hours 2
- Dosing for parenteral cefotaxime: 150 mg/kg per day, divided every 6-8 hours 2
Alternative Options:
- Amoxicillin-clavulanate can be used for beta-lactamase-producing E. coli, Klebsiella species, and Enterobacter species 3
- Oral dosing: 20-40 mg/kg per day in 3 doses 2
Treatment Duration and Monitoring
- Total course of therapy should be 7-10 days for uncomplicated UTIs 1
- For hospitalized patients with upper UTIs, switch to oral therapy after at least 48 hours of clinical improvement and adequate oral intake 1
- Obtain follow-up urine culture 7 days after completing therapy to confirm cure 4
Special Considerations
Severity Assessment
- Initial management of upper UTIs (pyelonephritis) should be in a hospital setting 1
- Patients who are "toxic" or unable to retain oral intake should receive parenteral antibiotics initially 2
- Switch to oral therapy after resolution of systemic inflammatory response (typically 48 hours) 1
Antibiotic Selection Caveats
- Avoid nitrofurantoin for treatment of pyelonephritis as it doesn't achieve adequate serum concentrations 2
- Adjust antibiotic therapy based on culture and sensitivity results when available 1
- For patients with history of infections caused by resistant organisms, carbapenems are suggested as first-line therapy 1
Common Pitfalls to Avoid
- Do not use trimethoprim-sulfamethoxazole in the third trimester due to risk of neonatal hyperbilirubinemia and kernicterus 5
- Avoid prolonged use of aminoglycosides due to potential ototoxicity and nephrotoxicity risks 1
- Do not delay treatment of symptomatic UTIs as they can lead to serious maternal and fetal complications including preterm delivery and low birth weight 5, 6
By following this treatment algorithm for UTIs in the third trimester, clinicians can effectively manage infections while minimizing risks to both mother and fetus.